Private Capital Group’s Axsome Therapeutics AXSM Stock Holding History

Private Capital Group’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$24K	Buy	633 +104	+20%	+$3.29K	0.02%	763
2022 Q1	$22K	Buy	529 +37	+8%	+$1.15K	0.01%	986
2021 Q4	$19K	Buy	492 +47	+11%	+$1.73K	﹤0.01%	1077
2021 Q3	$15K	Sell	445 -302	-40%	-$11.8K	﹤0.01%	1186
2021 Q2	$50K	Buy	747 +235	+46%	+$14.1K	0.01%	669
2021 Q1	$29K	Buy	+512	New	+$36K	0.01%	864

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Private Capital Group's AXSM Position: Q2 2022 in Review

Private Capital Group increased its Axsome Therapeutics (AXSM) stake by 20% in Q2 2022, buying an estimated $3.29K and bringing the position to 633 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #763.

Private Capital Group first reported a position in AXSM in Q1 2021 and has held it in 6 quarters since. The position peaked at $50K in Q2 2021. 174 funds tracked by Wall St. Rank hold AXSM as of Q2 2022.

Private Capital Group held 633 shares of Axsome Therapeutics worth $24K as of Q2 2022.
Private Capital Group bought 104 Axsome Therapeutics shares in Q2 2022, an estimated $3.29K.
Axsome Therapeutics made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #763 holding.
Private Capital Group first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 6 quarters since.
Private Capital Group's Axsome Therapeutics position peaked at $50K in Q2 2021.
174 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.